题名 | Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke |
作者 | |
发表日期 | 2017-03 |
发表期刊 | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | aspirin resistance genetic variants ischemic stroke outcome pharmacogenetics |
其他关键词 | GENETIC POLYMORPHISMS ; PLATELET ACTIVATION ; RESISTANCE ; P2Y(12) ; RISK ; DETERIORATION |
摘要 | Background:The effect of gene variants and their interactions on response to aspirin and clinical adverse outcomes after an acute ischemic stroke (IS) is not fully understood. The aim of this study was to investigate the association of aspirin-relevant gene variants and their interactions with clinical adverse outcomes in IS patients taking aspirin. Methods:A total of 14 variants from six genes encoding COX enzymes (COX-1, COX-2), platelet membrane receptors (TXAS1, P2Y1, P2Y12) and glycoprotein receptor (GPIIIa) were examined in 850 acute IS patients. Gene-gene interactions were analyzed using generalized multifactor dimensionality reduction (GMDR) analysis. All patients were followed up for 1 year after admission. Primary outcome was a composite of recurrent ischemic stroke (RIS), myocardial infarction (MI) and death. Results:The primary outcome occurred in 112 (13.5%) patients (81 RIS, 16 MI and 15 deaths). There were no significant differences in the frequencies of the genotypes of the 14 variants between the patients with and without primary outcome using single-locus analytical approach. However, there was significant gene-gene interaction among rs20417, rs1371097 and rs2317676. The high-risk interactive genotypes of rs20417, rs1371097 and rs2317676 were independently associated with primary adverse outcome of RIS, MI, and death after acute IS. Conclusion:The three-loci interactions are associated with sensitivity of IS patients to aspirin and aspirin-induced adverse clinical events. The combinatorial analysis used in this study may be helpful to elucidate complex genetic risk of aspirin resistance (AR). |
资助项目 | Deyang City Science and Technology Research Foundation [2014SZ035]; Scientific Research Foundation of Chengdu University of Traditional Chinese Medicine [YYZX1510] |
出版者 | SAGE PUBLICATIONS LTD |
出版地 | LONDON |
ISSN | 1756-2856 |
EISSN | 1756-2864 |
卷号 | 10期号:3页码:161-170 |
DOI | 10.1177/1756285616681943 |
页数 | 10 |
WOS类目 | Clinical Neurology |
WOS研究方向 | Neurosciences & Neurology |
WOS记录号 | WOS:000396212700002 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 28344655 |
PMC记录号 | PMC5349374 |
SCOPUSEID | 2-s2.0-85015017122 |
通讯作者地址 | [Yi, Xingyang]Department of Neurology,People's Hospital of Deyang City,173 North Taishan Road,Deyang, Sichuan,618000,China |
Scopus学科分类 | Pharmacology;Neurology;Neurology (clinical) |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/3598 |
专题 | 第二临床医学院、附属第二医院、育英儿童医院_神经病学_神经内科 其他_附属第三医院(瑞安市人民医院) |
通讯作者 | Yi, Xingyang |
作者单位 | 1.Department of Neurology,People's Hospital of Deyang City,173 North Taishan Road,Deyang, Sichuan,618000,China; 2.Department of Neurology,2nd Affiliated Hospital and Yuying Children Hospital,Wenzhou Medical University,No 109, Xueyuan West Road,Wenzhou, Zhejiang,325027,China; 3.Department of Neurology,Third Affiliated Hospital,Wenzhou Medical College,Wenzhou, Zhejiang,China |
推荐引用方式 GB/T 7714 | Yi, Xingyang,Han, Zhao,Zhou, Qiang,et al. Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke[J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS,2017,10(3):161-170. |
APA | Yi, Xingyang, Han, Zhao, Zhou, Qiang, Lin, Jing, & Wang, Chun. (2017). Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 10(3), 161-170. |
MLA | Yi, Xingyang,et al."Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke".THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS 10.3(2017):161-170. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论